108 related articles for article (PubMed ID: 31962142)
21. Characterization of the class I-restricted gp100 melanoma peptide-stimulated primary immune response in tumor-free vaccine-draining lymph nodes and peripheral blood.
Walker EB; Miller W; Haley D; Floyd K; Curti B; Urba WJ
Clin Cancer Res; 2009 Apr; 15(7):2541-51. PubMed ID: 19318471
[TBL] [Abstract][Full Text] [Related]
22. 4-1BB-mediated expansion affords superior detection of in vivo primed effector memory CD8+ T cells from melanoma sentinel lymph nodes.
Sluijter BJ; van den Hout MF; Stam AG; Lougheed SM; Suhoski MM; van den Eertwegh AJ; van den Tol MP; van Leeuwen PA; Meijer S; Scheper RJ; June CH; de Gruijl TD; Santegoets SJ
Clin Immunol; 2010 Nov; 137(2):221-33. PubMed ID: 20708974
[TBL] [Abstract][Full Text] [Related]
23. Co-transfer of tumor-specific effector and memory CD8+ T cells enhances the efficacy of adoptive melanoma immunotherapy in a mouse model.
Contreras A; Beems MV; Tatar AJ; Sen S; Srinand P; Suresh M; Luther TK; Cho CS
J Immunother Cancer; 2018 May; 6(1):41. PubMed ID: 29843822
[TBL] [Abstract][Full Text] [Related]
24. Altered frequency of CD8
Rostamzadeh D; Haghshenas MR; Daryanoosh F; Samadi M; Hosseini A; Ghaderi A; Mojtahedi Z; Babaloo Z
J Cell Physiol; 2019 Jul; 234(7):11986-11998. PubMed ID: 30623416
[TBL] [Abstract][Full Text] [Related]
25. IL-12 priming during in vitro antigenic stimulation changes properties of CD8 T cells and increases generation of effector and memory cells.
Chang J; Cho JH; Lee SW; Choi SY; Ha SJ; Sung YC
J Immunol; 2004 Mar; 172(5):2818-26. PubMed ID: 14978082
[TBL] [Abstract][Full Text] [Related]
26. Dendritic cells charged with apoptotic tumor cells induce long-lived protective CD4+ and CD8+ T cell immunity against B16 melanoma.
Goldszmid RS; Idoyaga J; Bravo AI; Steinman R; Mordoh J; Wainstok R
J Immunol; 2003 Dec; 171(11):5940-7. PubMed ID: 14634105
[TBL] [Abstract][Full Text] [Related]
27. Neutrophils transport antigen from the dermis to the bone marrow, initiating a source of memory CD8+ T cells.
Duffy D; Perrin H; Abadie V; Benhabiles N; Boissonnas A; Liard C; Descours B; Reboulleau D; Bonduelle O; Verrier B; Van Rooijen N; Combadière C; Combadière B
Immunity; 2012 Nov; 37(5):917-29. PubMed ID: 23142782
[TBL] [Abstract][Full Text] [Related]
28. T cells contribute to tumor progression by favoring pro-tumoral properties of intra-tumoral myeloid cells in a mouse model for spontaneous melanoma.
Lengagne R; Pommier A; Caron J; Douguet L; Garcette M; Kato M; Avril MF; Abastado JP; Bercovici N; Lucas B; Prévost-Blondel A
PLoS One; 2011; 6(5):e20235. PubMed ID: 21633700
[TBL] [Abstract][Full Text] [Related]
29. IL-15-dependent upregulation of GITR on CD8 memory phenotype T cells in the bone marrow relative to spleen and lymph node suggests the bone marrow as a site of superior bioavailability of IL-15.
Snell LM; Lin GH; Watts TH
J Immunol; 2012 Jun; 188(12):5915-23. PubMed ID: 22581858
[TBL] [Abstract][Full Text] [Related]
30. Polyfunctional response by ImmTAC (IMCgp100) redirected CD8
Boudousquie C; Bossi G; Hurst JM; Rygiel KA; Jakobsen BK; Hassan NJ
Immunology; 2017 Nov; 152(3):425-438. PubMed ID: 28640942
[TBL] [Abstract][Full Text] [Related]
31. Tumor-infiltrating CD62L+PD-1-CD8 T cells retain proliferative potential via Bcl6 expression and replenish effector T cells within the tumor.
Gong Y; Suzuki T; Kozono H; Kubo M; Nakano N
PLoS One; 2020; 15(8):e0237646. PubMed ID: 32845913
[TBL] [Abstract][Full Text] [Related]
32. Reversing tumor immune suppression with intratumoral IL-12: activation of tumor-associated T effector/memory cells, induction of T suppressor apoptosis, and infiltration of CD8+ T effectors.
Kilinc MO; Aulakh KS; Nair RE; Jones SA; Alard P; Kosiewicz MM; Egilmez NK
J Immunol; 2006 Nov; 177(10):6962-73. PubMed ID: 17082611
[TBL] [Abstract][Full Text] [Related]
33. Enrichment of memory T cells and other profound immunological changes in the bone marrow from untreated breast cancer patients.
Feuerer M; Rocha M; Bai L; Umansky V; Solomayer EF; Bastert G; Diel IJ; Schirrmacher V
Int J Cancer; 2001 Apr; 92(1):96-105. PubMed ID: 11279612
[TBL] [Abstract][Full Text] [Related]
34. Tumor-Specific Effector CD8+ T Cells That Can Establish Immunological Memory in Humans after Adoptive Transfer Are Marked by Expression of IL7 Receptor and c-myc.
Chandran SS; Paria BC; Srivastava AK; Rothermel LD; Stephens DJ; Kammula US
Cancer Res; 2015 Aug; 75(16):3216-26. PubMed ID: 26100671
[TBL] [Abstract][Full Text] [Related]
35. Dendritic cell immunization route determines CD8+ T cell trafficking to inflamed skin: role for tissue microenvironment and dendritic cells in establishment of T cell-homing subsets.
Dudda JC; Simon JC; Martin S
J Immunol; 2004 Jan; 172(2):857-63. PubMed ID: 14707056
[TBL] [Abstract][Full Text] [Related]
36. Immunogenicity without immunoselection: a mutant but functional antioxidant enzyme retained in a human metastatic melanoma and targeted by CD8(+) T cells with a memory phenotype.
Sensi M; Nicolini G; Zanon M; Colombo C; Molla A; Bersani I; Lupetti R; Parmiani G; Anichini A
Cancer Res; 2005 Jan; 65(2):632-40. PubMed ID: 15695408
[TBL] [Abstract][Full Text] [Related]
37. CXCR4, but not CXCR3, drives CD8
Goedhart M; Gessel S; van der Voort R; Slot E; Lucas B; Gielen E; Hoogenboezem M; Rademakers T; Geerman S; van Buul JD; Huveneers S; Dolstra H; Anderson G; Voermans C; Nolte MA
Eur J Immunol; 2019 Apr; 49(4):576-589. PubMed ID: 30707456
[TBL] [Abstract][Full Text] [Related]
38. TGF-beta 1 attenuates the acquisition and expression of effector function by tumor antigen-specific human memory CD8 T cells.
Ahmadzadeh M; Rosenberg SA
J Immunol; 2005 May; 174(9):5215-23. PubMed ID: 15843517
[TBL] [Abstract][Full Text] [Related]
39. Protection against influenza A virus by memory CD8 T cells requires reactivation by bone marrow-derived dendritic cells.
Castiglioni P; Hall de S; Jacovetty EL; Ingulli E; Zanetti M
J Immunol; 2008 Apr; 180(7):4956-64. PubMed ID: 18354221
[TBL] [Abstract][Full Text] [Related]
40. Maintenance of CD8
Siracusa F; Alp ÖS; Maschmeyer P; McGrath M; Mashreghi MF; Hojyo S; Chang HD; Tokoyoda K; Radbruch A
Eur J Immunol; 2017 Nov; 47(11):1900-1905. PubMed ID: 28815584
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]